Bioscript group acquired Valid Insight and Fortis Pharma in 2021 in order to extend their services in the market access and medical communications space. Syner-G group, a provider of CMC ...

Chennai real estate: G Square Group acquired 714-acre project from Rakindo’s Kovai Hills project in Coimbatore for ₹707 crore, to develop as integrated township Chennai-based real estate firm ...

The latest price target for Mereo BioPharma Group (NASDAQ:MREO) was reported by Needham on May 13, 2025. The analyst firm set a price target for $7.00 expecting MREO to rise to within 12 months (a ...

PARIS (Reuters) -France's Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for up to $9.5 billion to boost its position in rare immunology diseases, in the biggest deal struck ...

Sanofi SA will buy Blueprint Medicines Corp. for $9.1 billion equity value, in a deal that sees the European pharmaceutical firm expand its rare immunological disease portfolio. Sanofi will pay $ ...

Sanofi to Buy US Biopharma Group Blueprint for up to $9.5 Billion By Dominique Patton and Geert De Clercq PARIS (Reuters) -France's Sanofi has agreed to buy U.S.-based Blueprint Medicines ...

PARIS — France's Sanofi has agreed to buy US-based Blueprint Medicines Corp. for over $9 billion to boost its position in rare immunology diseases, in what would be the biggest health care deal in ...

G-III Apparel Group, LTD. NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- G-III Apparel Group, Ltd. (NASDAQ: GIII) a global fashion leader with expertise in design, sourcing, and marketing, today ...

PARIS (Reuters) -France’s Sanofi (NASDAQ:SNY) has agreed to buy U.S.-based Blueprint Medicines (NASDAQ:BPMC) Corporation for up to $9.5 billion to boost its position in rare immunology diseases ...